Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature

MLA

Samuel Asanad, et al. “Retinal Ganglion Cell Dysfunction in Preclinical Alzheimer’s Disease: An Electrophysiologic Biomarker Signature.” Scientific Reports, vol. 11, no. 1, Mar. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-021-85010-1.

APA

Samuel Asanad, Christian M. Felix, Michele Fantini, Michael G. Harrington, Alfredo A. Sadun, & Rustum Karanjia. (2021). Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature. Scientific Reports, 11(1), 1–9. https://doi.org/10.1038/s41598-021-85010-1

Chicago

Samuel Asanad, Christian M. Felix, Michele Fantini, Michael G. Harrington, Alfredo A. Sadun, and Rustum Karanjia. 2021. “Retinal Ganglion Cell Dysfunction in Preclinical Alzheimer’s Disease: An Electrophysiologic Biomarker Signature.” Scientific Reports 11 (1): 1–9. doi:10.1038/s41598-021-85010-1.